Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide.

The identification of antigenic peptides presented on the tumor cell surface by HLA class I molecules and recognized by tumor-specific cytotoxic T lymphocytes may lead to a peptide vaccine capable of inducing protective cellular immunity. We demonstrate that both HLA-A2-restricted breast and ovarian...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Proc Natl Acad Sci U S A
Principais autores:	Peoples, G E, Goedegebuure, P S, Smith, R, Linehan, D C, Yoshino, I, Eberlein, T J
Formato:	Artigo
Idioma:	Inglês
Publicado em:	National Academy of Sciences 1995
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC42754/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7831305/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.92.2.432
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!